Shares of Krsnaa Diagnostics Ltd rose sharply on Tuesday, July 8, climbing by 5.6% to ₹782.00 on the NSE after the company announced a positive development regarding its Rajasthan government project. The stock gained ₹41.45 from its previous close of ₹740.55.
In a regulatory filing dated July 7, 2025, Krsnaa Diagnostics informed exchanges that the Hon’ble High Court of Rajasthan had ruled in favor of the company and its consortium partner Telecommunications Consultants India Ltd (TCIL), in a case concerning the Free Diagnostics Initiative under the National Health Mission (NHM) in Rajasthan.
Following the court order, the Government of Rajasthan issued a fresh Letter of Acceptance (LoA) to the company and its consortium. Krsnaa Diagnostics will now move forward with signing the agreement with the state authority, enabling it to provide laboratory services across the state under the hub-and-spoke model.
The company assured investors that it remains committed to supporting the state’s healthcare initiatives and will continue updating stakeholders about further progress.
At the day’s high, the stock traded between ₹770.00 and ₹789.00, with a market capitalization of ₹25.53 billion and a P/E ratio of 33.40.
The announcement appears to have boosted investor sentiment, reflecting confidence in the company’s ability to execute large-scale healthcare projects successfully.
